What are the nitrofurantoin dosing adjustments for adults, children, and elderly patients based on estimated glomerular filtration rate (eGFR) categories?

Nitrofurantoin Dosage Adjustment by Age and Renal Function

Nitrofurantoin should NOT be used in patients with creatinine clearance (CrCl) <30 mL/min, regardless of age, based on expert consensus guidelines 1. For patients with CrCl ≥30 mL/min, standard dosing applies without adjustment.

Dosing by Renal Function (GFR/CrCl Categories)

CrCl <30 mL/min: AVOID

• Do not prescribe nitrofurantoin in this population 1
• Risk of peripheral neuropathy increases substantially with renal impairment 2
• Subtherapeutic urine concentrations may occur, reducing efficacy
• The FDA label specifically warns that conditions including renal impairment (CrCl <60 mL/min or clinically significant elevated serum creatinine) increase the risk of severe or irreversible peripheral neuropathy 2

CrCl 30-60 mL/min: USE WITH STANDARD DOSING

• Standard adult dose: 100 mg twice daily for 5-7 days (treatment) or 50-100 mg once daily (prophylaxis)
• Despite older recommendations to avoid nitrofurantoin at CrCl <60 mL/min, recent evidence demonstrates safety and efficacy in this range 3, 4, 5
• A 2015 population-based study found no increased treatment failure in patients with median eGFR of 38 mL/min compared to those with eGFR of 69 mL/min 3
• Nitrofurantoin was associated with lower odds of acute kidney injury compared to trimethoprim in patients with eGFR 30-60 mL/min 4
• The 2015 Beers Criteria update revised the avoidance threshold from CrCl <60 to <30 mL/min based on this emerging evidence 6

CrCl >60 mL/min: STANDARD DOSING

• Treatment: 100 mg twice daily for 5-7 days
• Prophylaxis: 50 mg once daily preferred over 100 mg (better safety profile with equivalent efficacy) 7
• No dose adjustment required

Age-Specific Considerations

Adults (18-64 years)

• Standard dosing: 100 mg twice daily for treatment
• No adjustment needed unless renal impairment present

Older Adults (≥65 years)

• Same dosing as younger adults IF CrCl ≥30 mL/min
• Critical caveat: Always calculate CrCl—serum creatinine alone is unreliable in elderly due to decreased muscle mass 1
• Use Cockcroft-Gault equation for drug dosing decisions (not MDRD or CKD-EPI, which can produce clinically significant discrepancies) 8
• Monitor closely for peripheral neuropathy, pulmonary reactions, and hepatotoxicity 2
• For prophylaxis, prefer 50 mg daily over 100 mg to minimize adverse events (cough, dyspnea, nausea) 7

Children

• Treatment: 5-7 mg/kg/day divided into 4 doses (maximum 400 mg/day)
• Prophylaxis: 1-2 mg/kg/day as single dose (maximum 100 mg/day)
• Avoid in infants <1 month (risk of hemolytic anemia)
• Same renal function thresholds apply: avoid if CrCl <30 mL/min

Critical Safety Warnings

Absolute Contraindications

• CrCl <30 mL/min 1
• Infants <1 month of age
• Pregnancy at term (38-42 weeks gestation)
• G6PD deficiency 2

High-Risk Populations Requiring Enhanced Monitoring

Even with adequate renal function, the following conditions increase risk of peripheral neuropathy 2:

• Anemia
• Diabetes mellitus
• Electrolyte imbalance
• Vitamin B deficiency
• Debilitating diseases

Pulmonary Toxicity Risk

• Chronic pulmonary reactions occur with prolonged use (≥6 months) and may cause irreversible pulmonary fibrosis 2
• Acute reactions (fever, cough, dyspnea, eosinophilia) typically occur within first week 2
• Risk is greater when chronic reactions are not recognized early
• Avoid long-term continuous therapy in elderly patients

Practical Algorithm for Prescribing

1. Calculate CrCl using Cockcroft-Gault equation (not eGFR from lab reports)
2. If CrCl <30 mL/min: Choose alternative antibiotic (ciprofloxacin, trimethoprim-sulfamethoxazole)
3. If CrCl 30-60 mL/min: Nitrofurantoin is safe; use standard dosing (100 mg BID for treatment)
4. If CrCl >60 mL/min: Standard dosing without concern
5. For prophylaxis in any renal category: Prefer 50 mg daily over 100 mg daily
6. Monitor all patients for neuropathy symptoms (paresthesias, weakness) and pulmonary symptoms (cough, dyspnea)

Common Pitfalls to Avoid

• Do not rely on serum creatinine alone in elderly patients—always calculate CrCl 1
• Do not use eGFR from lab reports for drug dosing decisions; use Cockcroft-Gault CrCl 8
• Do not prescribe for pyelonephritis or complicated UTI—nitrofurantoin achieves inadequate tissue concentrations
• Do not continue beyond 7 days for treatment or use for chronic suppression without careful risk-benefit assessment 2
• Do not assume all patients with CrCl 30-60 mL/min need dose adjustment—they do not 3, 4, 6